osimertinib,gefitinib
Astrazeneca
['lcsm,(-blcsm)', 'apple trial', 'nsclc', 'sclc']
#esmo22 #lcsm presented the apple trial in egfr+ nsclc: osi treatment based on plasma t790m study design, here! 
Thoracic oncologist & researcher @IEOufficiale; @myESMO Press & Media Chair; #LungCancer Molecular target-believer #LCSM